Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTR1A | P08908 | 2/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.42 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.42 |
| ▸ | FABP3 | P05413 | 1/20 | 0.41 |
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16667567 | 1.00 | THRB (0.45) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL16558586 | 1.00 | THRB (0.45) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL28329138 | 0.92 | TSHR (0.51) | THRBCHRM5CHRM1CHRM3FABP3 | |
| SCHEMBL2946708 | 0.91 | TSHR (0.49) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL28831183 | 0.91 | TSHR (0.38) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL2946928 | 0.90 | TSHR (0.51) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL28595957 | 0.89 | TSHR (0.60) | THRBFABP3MAPTTSHRADRA1A | |
| SCHEMBL13333174 | 0.89 | CHRM5 (0.41) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL31091982 | 0.88 | THRB (0.55) | THRBTSHRAPEX1ALDH1A1BTN3A1 | |
| SCHEMBL15194 | 0.88 | THRB (0.55) | THRBTSHRAPEX1ALDH1A1BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3779457-B1 | METHOD AND REAGENT FOR MEASURING UPTAKE PERFORMANCE OF LIPOPROTEIN | SYSMEX CORP (JP) | 2026-04-29 | — | — | EP | claimed |
| EP-4714453-A1 | USE OF STRUCTURE FOR NUCLEIC ACID DELIVERY IN TREATMENT OF HEMATOPOIETIC TUMOR | Japan Science and Technology Agency (JP) | 2026-03-25 | — | — | EP | claimed |
| US-20250195442-A1 | POLYMER-COATED NANOPARTICLES | 20MED THERAPEUTICS B.V. (NL) | 2025-06-19 | — | — | US | claimed |
| US-20250066736-A1 | HIGH-THROUGHPUT 3D CELL SPHEROID CULTURE CHIP, PREPARATION PROCESS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-02-27 | — | — | US | claimed |
| WO-2025029684-A1 | LOW VOLUME RESUSCITANTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF WASHINGTON (US) | 2025-02-06 | — | — | WO | claimed |
| EP-4489733-A1 | POLYMER-COATED NANOPARTICLES | 20MED Therapeutics B.V. (NL) | 2025-01-15 | — | — | EP | claimed |
| CN-116731248-B | Biomedical coating and preparation method and application thereof | 广东省科学院化工研究所 | 2024-12-10 | — | — | CN | claimed |
| WO-2024242065-A1 | USE OF STRUCTURE FOR NUCLEIC ACID DELIVERY IN TREATMENT OF HEMATOPOIETIC TUMOR | 国立研究開発法人科学技術振興機構 | 2024-11-28 | — | — | WO | claimed |
| US-12097113-B2 | Bioprosthetic valve and preparation method thereof | SICHUAN UNIVERSITY (CN) | 2024-09-24 | — | — | US | claimed |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-18 | — | — | US | claimed |
| EP-2253370-B1 | Hollow fibre membranes having improved performance | GAMBRO LUNDIA AB (SE) | 2014-10-01 | — | — | EP | claimed |
| EP-1930422-B1 | METHOD FOR PRODUCING CDNA AND RNA CHAINS AND NUCLEOTIDE-IMMOBILIZED SUPPORT | SUMITOMO BAKELITE CO (JP) | 2013-01-23 | — | — | EP | claimed |
| US-20110274734-A1 | FUNCTIONALIZED CHEMICALLY INERT POLYMERS FOR COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2011-11-10 | — | — | US | claimed |
| WO-2010133612-A1 | MEMBRANES HAVING IMPROVED PERFORMANCE | GAMBRO LUNDIA AB (SE) | 2010-11-25 | — | — | WO | claimed |
| EP-2253370-A1 | Membranes having improved performance | Gambro Lundia AB (SE) | 2010-11-24 | — | — | EP | claimed |
| EP-2170708-A2 | OPHTHALMIC SOLUTIONS | Bausch & Lomb Incorporated (US) | 2010-04-07 | — | — | EP | claimed |
| WO-2009002703-A2 | OPHTHALMIC SOLUTIONS | BAUSCH & LOMB INCORPORATED (US) | 2008-12-31 | — | — | WO | claimed |
| WO-2007008408-A2 | FUNCTIONALIZED CHEMICALLY INERT POLYMERS FOR COATINGS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070009565-A1 | Functionalized chemically inert polymers for coatings | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-01-11 | — | — | US | claimed |
| EP-1152242-B1 | CONTAINER FOR IMMUNOASSAY | SUMITOMO BAKELITE CO (JP) | 2005-12-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195442-A1 | POLYMER-COATED NANOPARTICLES | CD47, CD63, EEA1 | THRB 4848/4885CHRM5 4477/4885CHRM1 4721/4885 |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | HNRNPH3, RNASEH1, HNRNPA1 | THRB 3469/4885CHRM5 4096/4885CHRM1 2724/4885 |
| US-20110274734-A1 | FUNCTIONALIZED CHEMICALLY INERT POLYMERS FOR COATINGS | CD44, EPCAM, SIGLEC7 | THRB 2916/4885CHRM5 1179/4885CHRM1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.